PNT

POINT Biopharma Global Inc. Common Stock
PNT

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

PNT was delisted on the 26th of December, 2023.

Back to rankings
 

About: POINT Biopharma Global Inc is a clinical-stage pharmaceutical company focused on the development and commercialization of radioligand therapies for the treatment of cancer. Its product pipeline includes PNT2002; PNT2004; PNT2003; PNT2001 and others.

Employees: 129

Healthcare Drug Manufacturers - General
Price charts implemented using Lightweight Charts™